Department of Health and Human Services

Treasury and HHS ConfirmationsHouse Appropriations Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies · April 16, 2026 · 119th Congress
The House Appropriations Subcommittee on Labor, HHS, Education convened this hearing to examine Secretary Robert F. Begins at ▶ 0:46:19
Transcript
Highlights

Title

FY2027 HHS budget hearing on vaccines, Medicaid, and rural health

Purpose

The House Appropriations Subcommittee on Labor, HHS, Education convened this hearing to examine Secretary Robert F. Kennedy Jr.'s Fiscal Year 2027 budget request for the Department of Health and Human Services, covering proposed cuts to CDC, NIH, and SAMHSA alongside rural health, vaccine policy, and grant-funding delays. Chairman Robert Aderholt (R-AL) and Ranking Member Laurel Lee (D-FL) opened with sharply differing views on the administration's record, before members questioned Kennedy on measles outbreaks, Medicaid, raw milk safety, glyphosate, mercury regulation, and fraud enforcement. Begins at▶ 0:46:19

Who spoke

• Chairman Robert Aderholt (R-AL)▶ 0:46:19: Praised HHS's investigation into 13 states for Weldon Amendment violations▶ 0:46:19 and the $50 billion Rural Health Transformation Fund▶ 0:46:48; later pressed Kennedy on FDA's mifepristone black-box warning and adverse-event reporting gaps▶ 1:04:40 and on the Medicare hospital wage index's harm to rural, low-wage states▶ 1:07:44.

• Ranking Member Laurel Lee (D-FL)▶ 0:48:34: Praised HHS's microplastics water-contaminant classification▶ 0:48:50; criticized the budget's proposed $16.5 billion (14%) cut to health agencies▶ 0:51:02, nearly 300 CDC staff on paid administrative leave for over a year▶ 0:53:12, the firing of CDC Director Susan Monarrez▶ 0:54:51, and OMB's 15-day funding schedules delaying grants▶ 0:56:53; said Congress will reject proposed cuts to NIH, CDC, SAMHSA, and LIHEAP▶ 0:57:20.

• Secretary Robert F. Kennedy Jr., HHS▶ 0:59:05: Outlined "Make America Healthy Again" achievements including most-favored-nation drug pricing with 16 pharmaceutical companies▶ 0:59:59 and the $50 billion Rural Health Transformation Fund▶ 1:02:46; declined to discuss mifepristone due to Louisiana litigation▶ 1:05:39; said HHS employment fell from 82,000 to 62,000 and is rebuilding to 72,000 with 12,000 more hires▶ 1:24:36; defended holding up GAVI funding over thimerosal-containing vaccines▶ 2:12:37; said he fired all 17 members of the CDC vaccine advisory panel▶ 2:23:46.

• Rep. Mark Pocan (D-WI)▶ 1:23:45: Questioned HHS staffing levels and reasons for cuts, disputing that reductions reflected employee competence▶ 1:23:45▶ 1:26:15; asked about CDC morale and rehiring of recalled employees▶ 1:29:48.

• Rep. Jake Ellzey (R-TX)▶ 1:31:20: Asked about anthrax countermeasures in the strategic stockpile▶ 1:31:20 and Chinese cybersecurity risks in medical devices▶ 1:32:15; shared a personal story about UK hospital care▶ 1:34:07.

• A committee member (Spokane-area representative)▶ 1:34:44: Raised a prior unfulfilled promise for a follow-up call on the 988 line and LGBT funding▶ 1:35:05; pressed on whether HHS should timely expend appropriated funds▶ 1:36:02 and questioned Kennedy on glyphosate's carcinogenicity given his past statements▶ 1:37:15 and on animal welfare at Richland Farms beagle breeding facility supplying NIH-funded research▶ 1:39:35.

• A committee member (Oklahoma representative)▶ 1:41:07: Praised NIH investment and hosting NIH Director Bhattacharya▶ 1:41:23; asked which NIH research areas would be cut or expanded▶ 1:43:04 and about China's growing lead in Phase 1 clinical trials▶ 1:45:09.

• Rep. Lois Frankel (D-FL)▶ 1:47:24: Pressed Kennedy on withheld GAVI vaccine funding▶ 1:47:24 and delayed approval of Florida's state-directed Medicaid payment program, citing a potential $4.5 billion shortfall▶ 1:49:18; criticized proposed elimination of Title X family planning and fall-prevention programs▶ 1:50:40.

• A committee member (following up on Chinese pharmaceutical/API issues)▶ 1:52:34: Asked about reshoring active pharmaceutical ingredient production▶ 1:53:01, BARDA contracting authority▶ 1:54:21, and rural provider cybersecurity▶ 1:55:38.

• A committee member (asking about chronic disease data)▶ 1:58:26: Challenged Kennedy's sourcing for claims about "the sickest generation"▶ 1:58:26 and pressed on LIHEAP elimination despite prior commitments▶ 1:59:37, then on racial health disparities and elimination of the National Institute on Minority Health▶ 2:02:49.

• Rep. Andrew Clyde (R-GA)▶ 2:05:03: Thanked Kennedy for expanded access to investigational drugs, citing a constituent's mitochondrial disease treatment▶ 2:05:34; asked about a new Title X "Protect Life" rule▶ 2:06:52 and Minnesota childcare fraud oversight▶ 2:08:36.

• Rep. Buddy Carter (R-GA)▶ 2:10:48: Challenged Kennedy on his past mercury-pollution advocacy versus the administration's rollback of the Mercury and Air Toxics Standards▶ 2:11:13, leading to a contentious exchange in which Kennedy said the decision was EPA's, not his▶ 2:12:37.

• A committee member (West Virginia representative)▶ 2:17:00: Praised coal-industry and NIOSH support▶ 2:18:48; asked about directing Child Care and Development Block Grant funds to kinship caregivers▶ 2:19:05 and fetal tissue research policy▶ 2:20:41.

• Rep. Madeleine Dean (D-PA)▶ 2:21:10: Cited rising measles cases (285 in 2024, ~2,500 in 2025, 1,700+ in early 2026) and three deaths▶ 2:22:21; confirmed with Kennedy that the MMR vaccine is safe and effective▶ 2:22:53 but criticized declining vaccination rates and the firing of all 17 ACIP members▶ 2:23:46; questioned proposed SAMHSA and mental-health funding cuts▶ 2:25:57.

• A committee member (discussing NIH indirect costs and Medicare Advantage)▶ 2:28:43: Praised scrutiny of sweetened-beverage SNAP spending▶ 2:29:03 and NIH indirect cost reforms▶ 2:30:24; raised Medicare Advantage "upcoding" concerns▶ 2:31:39 and asked about fraud, waste, and abuse crackdowns▶ 2:32:35.

• Rep. Chuck Fleischmann (R-TN)▶ 2:34:56: Asked about Medicare Part D coverage of non-opioid pain medications▶ 2:35:23 and enforcement funding against illegal Chinese vape imports▶ 2:37:38.

Key moments

• Lee said the budget proposes a $16.5 billion (14%) cut to health agencies, including 30% from CDC and $6 billion from NIH, and stated flatly "we are not going to do that"▶ 0:51:02▶ 0:57:46.

• Kennedy testified HHS employment dropped from 82,000 to 62,000 and is rebuilding to 72,000 with 12,000 new hires, framing prior cuts as a response to duplication (e.g., nine women's health offices, 27 HIV programs)▶ 1:24:36▶ 1:27:36.

• Kennedy confirmed HHS is withholding roughly $349 million in GAVI/childcare-related funds from Minnesota over alleged fraud, and separately holding up GAVI vaccine funding because it includes thimerosal-containing vaccines banned in Europe and the US▶ 2:09:24▶ 2:12:37.

• Sharp exchange: Rep. Carter repeatedly pressed Kennedy on the administration's rollback of mercury air-toxics rules given his career fighting mercury pollution; Kennedy repeatedly said it was an EPA decision he "doesn't know anything about," which Carter called "convenient amnesia"▶ 2:12:08.

• Dean cited MMR vaccination coverage dropping to 92.5%, below the 95% outbreak-prevention threshold, alongside 1,700+ measles cases and three deaths in early 2026; Kennedy disputed a causal link to his removal of the ACIP panel▶ 2:23:22▶ 2:24:35.

• Kennedy said HHS has identified major Medicaid/hospice fraud, including 500 terminated hospices in California and a case where a hotel was filled with fake hospice patients billing $6,000/month▶ 2:33:58▶ 2:34:27.

• On raw milk, Kennedy said FDA does not regulate raw milk (states do) and declined to advise against drinking it despite a Raw Farm cheddar recall linked to E. coli that sickened nine and hospitalized three▶ 1:16:34▶ 1:17:56.

• Frankel said Florida faces a $4.5 billion annual federal funding shortfall because CMS has not approved its state-directed Medicaid payment program; Kennedy replied HHS meets weekly with Florida officials▶ 1:49:18▶ 1:50:11.

• Kennedy testified China now conducts nearly 40% of global clinical trials (up from 3%) and produced more licensed drugs than the US this year, citing $325 million in reshoring investment for pharmaceutical ingredient production▶ 1:46:01▶ 1:53:07.

• On glyphosate, a member noted Kennedy has called it a likely carcinogen; Kennedy confirmed he still believes that but said he had "grave reservations" about the administration's executive order expanding its use, calling it a national security necessity given Chinese control of the supply chain▶ 1:37:45▶ 1:38:15.

Metadata

CommitteeHouse Appropriations Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies
Chamber / CongressHouse · 119th Congress
DateApril 16, 2026
TypeHearing
Witnesses
The Honorable Robert Kennedy Jr. — Secretary, U.S. Department of Health and Human Services
Videoyoutube
Transcript282 caption blocks · 19,332 words · 2:48:48 runtime
EventCongress.gov 119143